The responsibilities of the Advisory Board are: To assume a role of scientific and intellectual leadership for the development of FESP; To oversee FESP’s activities; To advise on the solicitation of proposals for new journals, books, etc.; To make recommendations on the renewal and balance of its own membership.
Current members (in alphabetical order)
1. Dr. Xiaoxia Sheng, President & CEO of Solipharma LLC
Dr. Sheng received her Ph.D. degree in Chemical Engineering from University of Minnesota, Twin Cities in 2004. After the post-doc training at Massachusetts Institute of Technology, she Lead the Solid State Property team at Abbott Laboratories between 2006 and 2010, and accomplished six projects on solid oral dosage form development. She founded Solipharma LLC in 2010, which focuses on pharmaceutical solid state science and enabling technology, offering API solid form screening and selection, preformulation, crystallization process development,and formulation development.
2. Dr. Kai Zhang, Professor at the National Engineering Research Center for Biomaterials, Sichuan University
Dr. Zhang obtained his Ph.D. from the University of Minnesota. Prior to his current academic position, Dr. Zhang was working at leading global orthopedic and spinal companies in the US for over seven years. His representative publications include one book and nine peer-reviewed journal articles with a total impact factor over 44. Dr. Zhang filed a total of 36 US and EU patent applications, and is now the inventor of 13 issued US and EU patents. Dr. Zhang has been on the Editorial Board of the “Journal of Biomedical Materials Research: Part B, Applied Biomaterials” since 2007.